Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
KLF4 is a key determinant in the development and progression of cerebral cavernous malformations
IFOM, Milan, Italy..
IFOM, Milan, Italy..
IFOM, Milan, Italy..
IFOM, Milan, Italy..
Show others and affiliations
2016 (English)In: EMBO Molecular Medicine, ISSN 1757-4676, E-ISSN 1757-4684, Vol. 8, no 1, 6-24 p.Article in journal (Refereed) Published
Resource type
Text
Abstract [en]

Cerebral cavernous malformations (CCMs) are vascular malformations located within the central nervous system often resulting in cerebral hemorrhage. Pharmacological treatment is needed, since current therapy is limited to neurosurgery. Familial CCM is caused by loss-of-function mutations in any of Ccm1, Ccm2, and Ccm3 genes. CCM cavernomas are lined by endothelial cells (ECs) undergoing endothelial-to-mesenchymal transition (EndMT). This switch in phenotype is due to the activation of the transforming growth factor beta/bone morphogenetic protein (TGFb/BMP) signaling. However, the mechanism linking Ccm gene inactivation and TGFb/ BMP-dependent EndMT remains undefined. Here, we report that Ccm1 ablation leads to the activation of a MEKK3-MEK5-ERK5MEF2 signaling axis that induces a strong increase in Kruppel-like factor 4 (KLF4) in ECs in vivo. KLF4 transcriptional activity is responsible for the EndMT occurring in CCM1-null ECs. KLF4 promotes TGFb/BMP signaling through the production of BMP6. Importantly, in endothelial-specific Ccm1 and Klf4 double knockout mice, we observe a strong reduction in the development of CCM and mouse mortality. Our data unveil KLF4 as a therapeutic target for CCM.

Place, publisher, year, edition, pages
2016. Vol. 8, no 1, 6-24 p.
Keyword [en]
CCM, EndMT, endothelial cells, KLF4, TGF beta-BMP
National Category
Basic Medicine
Identifiers
URN: urn:nbn:se:uu:diva-276831DOI: 10.15252/emmm.201505433ISI: 000368135800003PubMedID: 26612856OAI: oai:DiVA.org:uu-276831DiVA: diva2:903477
Funder
EU, European Research Council, 268870EU, European Research Council, ITN VESSEL 317250EU, European Research Council, ENDOSTEM-HEALTH-2009-241440
Note

De två första författarna delar förstaförfattarskapet

Available from: 2016-02-16 Created: 2016-02-16 Last updated: 2017-11-30Bibliographically approved

Open Access in DiVA

fulltext(2510 kB)158 downloads
File information
File name FULLTEXT01.pdfFile size 2510 kBChecksum SHA-512
58d75f62bd8eaa2f10aa94be7f10bc123e1150b7ff355d1e9f3e5a2d9a97f63819b109e8ecd5780ced580802705689553da0b9b3d6e55d3af2fe1caf8bef4f1d
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Dejana, Elisabetta
By organisation
Vascular Biology
In the same journal
EMBO Molecular Medicine
Basic Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 158 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 512 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf